KATE MOUNT: Open Payments
NPI 1629513023 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,368 in 52 payments from 16 companies in 2025. Trend: 2023 $542 · 2024 $965 · 2025 $1,368
Food & beverage: $1,368
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 17 | $455 |
| CVRx, Inc. | 1 | $160 |
| Actelion Pharmaceuticals US, Inc. | 6 | $153 |
| Amgen Inc. | 1 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Merck Sharp & Dohme LLC | 4 | $67 |
| PFIZER INC. | 3 | $61 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
Products named: FUROSCIX, Barostim Neo System, REPATHA, OPSYNVI, JARDIANCE, LEQVIO, VERQUVO, OPSUMIT.
Industry payments across AL — which companies pay providers there.
